Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality

2.

Breast Cancer Incidence Rises in Asian American Women

3.

Severe obesity associated with reduced prevalence of recommended cancer screenings

4.

Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.

5.

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot